KLRS

Kalaris Therapeutics

84 hedge funds and large institutions have $110M invested in Kalaris Therapeutics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$129K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$7.8M
2 +$2.94M
3 +$970K
4
BlackRock
BlackRock
New York
+$966K
5
State Street
State Street
Massachusetts
+$566K

Top Sellers

1 -$9.72M
2 -$2.92M
3 -$2.46M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$922K
5
Citadel Advisors
Citadel Advisors
Florida
-$736K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$69K
52
$68K
53
$66K
54
$66K
55
$59K
56
$56K
57
$55K
58
$52K
59
$51K
60
$50K
61
$50K
62
$49K
63
$48K
64
$48K
65
$44K
66
$44K
67
$41K
68
$26K
69
$25K
70
$22K
71
$18K
72
$15K
73
$15K
74
$10K
75
$9K